XPH Projected Dividend Yield

S&P Pharmaceuticals ETF/SPDR Series Trust ( NYSE : XPH )

SPDR S&P Pharmaceuticals is an open-end investment management company. The Fund seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. As of June 30 2015, the Fund's total assets and investment portfolio totaled $1,324,794,738 and $1,323,892,831, respectively.

27 YEAR PERFORMANCE RESULTS